Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
Resilience and vulnerability in individuals with chronic pain and physical disability.
Comparison of BLADE and conventional T2-TSE sequences for the sagittal visualization of the cervical spinal cord in multiple sclerosis patients - A case report.
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.
The New Era of Multiple Sclerosis Therapeutics.
Depression screening in Black Americans with multiple sclerosis.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Multiple sclerosis.
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
Experimental Autoimmune Encephalomyelitis in Mice.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
LSN MS guidelines for the management of multiple sclerosis.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Pages
« first
‹ previous
…
296
297
298
299
300
301
302
303
304
…
next ›
last »